Testosterone for Women- The Most Important Webinar and Testosterone Study to Date by Neal Rouzier, MD April 2023 April’s webinar will be the last in the series of webinars addressing
by Neal Rouzier, MD Treatment Scenario Recently, a Midwest NP was reported to her nursing board for prescribing excessive doses of testosterone. One of her gynecology-physician peers did not like
Testosterone for Women: Current AACE Guidelines vs What the Literature Says by Neal Rouzier, MD In Testosterone for Women Part 1: The Evidence and Benefits No One Talks About, I
Testosterone for Women: The Studies that Prove Testosterone is Absolutely Necessary for CVD Protection
Testosterone for Women: The Studies that Prove Testosterone is Absolutely Necessary for CVD Protection by Neal Rouzier, MD For the first several courses on Testosterone for Women, I addressed the
In the first course, Testosterone for Women (Part I), I reviewed the current controversy in prescribing testosterone to women. In a separate consensus paper that is different from the one discussed in the first course, the authors recommend testosterone replacement based on symptoms and signs and not on serum levels. In fact, in this second consensus paper from “experts that have experience in the field of testosterone administration,” the authors stressed the importance of replacing testosterone to improve symptoms and not by being guided by numbers or levels. These authors specifically emphasized that testosterone should be supplemented based on symptoms and not just on serum levels alone, as testosterone levels do not correlate with symptoms as per much of the medical literature. The authors also suggested that testosterone should be dosed and adjusted based on symptom improvement, and not by testosterone levels. The authors reiterated that no number (or testosterone level) denotes a deficiency as symptoms denote a deficiency. Furthermore, improvement in symptoms do not correlate with numbers either as all women will respond differently and not based on any number. So, in contrast to men where the guidelines state that we must follow levels and numbers, these guidelines for women recommend that we do not test baseline levels nor treatment levels, rather symptoms should guide treatment initiation.
A 45 year old female presents to you complaining of fatigue, loss of energy, weight gain, muscle pain, and weakness in exercising.
She read about the benefit of hormones in treating her condition, but her PMD is against the use of hormones. Although she is open to taking hormones, her PMD scared her into thinking that testosterone is somehow harmful. You assure her that testosterone is not harmful and that many of her symptoms will improve on testosterone supplementation.